NO20082909L - Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene - Google Patents

Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene

Info

Publication number
NO20082909L
NO20082909L NO20082909A NO20082909A NO20082909L NO 20082909 L NO20082909 L NO 20082909L NO 20082909 A NO20082909 A NO 20082909A NO 20082909 A NO20082909 A NO 20082909A NO 20082909 L NO20082909 L NO 20082909L
Authority
NO
Norway
Prior art keywords
lignan extracts
extracts
lignan
recovering
compositions containing
Prior art date
Application number
NO20082909A
Other languages
English (en)
Inventor
Mark W Empie
William Walter Fletcher
Thomas V Gottemoller
Richard D Grabiel
Lawrence P Karcher
Sigmund J Peterson
Sam Zhiyong Sun
Original Assignee
Archer Daniels Midland Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co filed Critical Archer Daniels Midland Co
Publication of NO20082909L publication Critical patent/NO20082909L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)

Abstract

Fremgangsmåter for å oppnå lignanekstrakter fra plantematerialer er angitt. Sammensetninger inkluderer lignanekstrakter så vel som anvendelser av lignanekstratene er også angitt.
NO20082909A 2005-12-02 2008-06-27 Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene NO20082909L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74208205P 2005-12-02 2005-12-02
US80965206P 2006-05-31 2006-05-31
PCT/US2006/046317 WO2007065023A2 (en) 2005-12-02 2006-12-04 Processes for obtaining lignan extracts and compositions containing the lignan extracts

Publications (1)

Publication Number Publication Date
NO20082909L true NO20082909L (no) 2008-08-21

Family

ID=37989179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082909A NO20082909L (no) 2005-12-02 2008-06-27 Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene

Country Status (8)

Country Link
US (1) US20070141178A1 (no)
EP (2) EP1973555A2 (no)
JP (1) JP2009518311A (no)
AU (1) AU2006320353A1 (no)
BR (1) BRPI0618232A2 (no)
IL (1) IL190611A0 (no)
NO (1) NO20082909L (no)
WO (1) WO2007065023A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008239619A (ja) * 2007-02-28 2008-10-09 Fuji Chem Ind Co Ltd 末梢血行改善組成物
DE102008039103A1 (de) * 2007-10-31 2009-05-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Gewinnung einer proteinhaltigen Lebensmittelzutat aus Leinschrot
JP2009240191A (ja) * 2008-03-31 2009-10-22 Shimizu Shoko Kaigisho 光照射によるリグナン類・リグニン類合成系遺伝子の発現増強
CN101838406B (zh) * 2010-05-21 2011-12-07 甘肃亚兰特种药材饮片生产有限公司 从亚麻籽中同时提取分离亚麻籽胶和亚麻木酚素的方法
US10532040B2 (en) * 2011-11-18 2020-01-14 Regents Of The University Of Minnesota Methods of treating cancer with herbacetin
WO2014050717A1 (ja) * 2012-09-27 2014-04-03 サントリーホールディングス株式会社 肌の状態の改善剤
WO2015013409A1 (en) * 2013-07-25 2015-01-29 Geophia Llc Banana fiber composite material
US9163197B1 (en) * 2014-05-28 2015-10-20 Milex Corporation Methods of extracting phytochemicals from sorghum bran
US9702868B1 (en) 2014-05-28 2017-07-11 Milo Insulation, LLC Method of measuring polyphenol antioxidants in sorghum and other plant matter and method of selection of specific sorghum varieties for extrusion purposes
CN104478954A (zh) * 2014-12-04 2015-04-01 山西宝山鼎盛科技有限公司 从亚麻粕中直接提取亚麻木酚素和高蛋白亚麻粕脱毒的方法
CN107935979A (zh) * 2017-11-29 2018-04-20 陶坤秀 从火龙果皮中提取花青素的方法
CN111771916A (zh) * 2020-07-09 2020-10-16 安徽农业大学 一种富含花青素的水稻降镉叶面阻控剂及其施用方法
CN113899841B (zh) * 2021-11-08 2023-05-12 黑龙江珍宝岛药业股份有限公司 银杏叶提取中间体或其制剂中松脂醇二葡萄糖苷的检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705618A (en) 1995-03-31 1998-01-06 Agriculture And Agri-Food Canada Process for extracting lignans from flaxseed
US5827256A (en) 1995-04-21 1998-10-27 Kimberly-Clark Worldwide, Inc Tampon having a protective finger sheath and a method of forming
FI982125A0 (fi) 1998-10-01 1998-10-01 Hk Ruokatalo Oyj Terveyteen myönteisesti vaikuttava elintarvike
US6498145B1 (en) 1999-06-16 2002-12-24 University Of Saskatchewan Technologies Incorporated Use of purified SDG as a hypotensive (vasodilator) agent
US6264853B1 (en) * 1999-06-21 2001-07-24 Agriculture And Agri-Food Canada Complex containing lignan, phenolic and aliphatic substances from flax and process for preparing
US6767565B2 (en) 2001-03-22 2004-07-27 Archer Daniels Midland Company Process for obtaining lignan
US20030144216A1 (en) * 2002-01-25 2003-07-31 Mikko Unkila Method for prevention of diseases in coeliac patients
KR101029223B1 (ko) * 2002-03-11 2011-04-14 산토리 홀딩스 가부시키가이샤 Ｓｄｇ의 제법 및 그 배합 음식물
US6673773B2 (en) * 2002-05-10 2004-01-06 University Of Saskatchewan Technologies Incorporated Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent

Also Published As

Publication number Publication date
WO2007065023A2 (en) 2007-06-07
IL190611A0 (en) 2008-11-03
BRPI0618232A2 (pt) 2011-08-23
AU2006320353A1 (en) 2007-06-07
WO2007065023A3 (en) 2007-11-22
EP1973555A2 (en) 2008-10-01
JP2009518311A (ja) 2009-05-07
EP2130544A2 (en) 2009-12-09
US20070141178A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
NO20082909L (no) Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene
NO20080784L (no) Histondeacetylaseinhibitorer
ATE465719T1 (de) Oral zerfallende zusammensetzung von olanzapin oder donepezil
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
IL265947A (en) Preparation of stansoporfin with a high degree of purification on a large scale
HK1117746A1 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
MX2009004343A (es) Compuestos organicos.
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
TW200738649A (en) Calcilytic compounds
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
WO2007099392A3 (en) Convergent synthesis of carbohydrate building blocks
WO2007016029A3 (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
MY146610A (en) Process of producing bleach boosters
AP2007004223A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
TW200716130A (en) Purified form of tanaproget
TW200806304A (en) Maitake mushroom extract and composition containing the same for enhance production of sebum
SI1853220T2 (sl) Proizvodni postopek za pastile, ki vsebujejo nesteroidno protivnetno zdravilo (NSAID), njihovi sestavki in njihova medicinska uporaba
TW200716656A (en) Processes for the preparation of paclitaxel
NO20074136L (no) Orale sammensetninger for forebygging av UV-skader
NO20076139L (no) Fremgangsmate for a fremstille blekeaktivatorer
TW200720287A (en) Improved process for the extraction of betulinic acid
NO20070186L (no) Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen
TW200712052A (en) Process of producing bleach boosters

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application